Your browser doesn't support javascript.
loading
All-cause mortality in patients with diabetes under glucagon-like peptide-1 agonists: A population-based, open cohort study.
Toulis, K A; Hanif, W; Saravanan, P; Willis, B H; Marshall, T; Kumarendran, B; Gokhale, K; Ghosh, S; Cheng, K K; Narendran, P; Thomas, G N; Nirantharakumar, K.
Afiliação
  • Toulis KA; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom; 424 General Military Hospital, Thessaloniki, Greece.
  • Hanif W; Diabetes Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Saravanan P; University of Warwick & George Eliot Hospital, Coventry, United Kingdom.
  • Willis BH; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Marshall T; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Kumarendran B; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Gokhale K; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Ghosh S; Diabetes Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Cheng KK; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.
  • Narendran P; Diabetes Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
  • Thomas GN; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom. Electronic address: gneilthomas@yahoo.co.uk.
  • Nirantharakumar K; Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom; Diabetes Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom. Electronic address: k.nirantharan@bham.ac.uk.
Diabetes Metab ; 43(3): 211-216, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28325589
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon / Liraglutida / Hipoglicemiantes Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon / Liraglutida / Hipoglicemiantes Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Grécia